Intra-Cellular Therapies' (NASDAQ:ITCI) Investors Will Be Pleased With Their Stellar 177% Return Over the Last Five Years

Simply Wall StDec 30 06:23 ET

When Will Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Turn A Profit?

Yahoo FinanceDec 28 09:41 ET

S&P 500 Futures Drop In Premarket Trading; Intra-Cellular Therapies, Avantor Lag

Dow JonesDec 17 07:30 ET

Wolfe's Top 12 Shorted Stocks: FSLR, BE, WBA, and More

Seeking AlphaDec 16 15:45 ET

Intra-Cellular Therapies Presents Data From The CAPLYTA Adjunctive MDD Phase 3 Program At The American College Of Neuropsychopharmacology Annual Meeting; Data Shows Robust Remission And Response Efficacy Rates In Patients Taking CAPLYTA, As Well As...

BenzingaDec 11 08:08 ET

Insider Sale: Chairman and CEO of $ITCI (ITCI) Sells 1,534 Shares

Quiver QuantitativeDec 6 18:16 ET